Soluble TIE2

2 papers1 finding

Human trial1

Interventions

1

Laromestrocel

downin humans1

1 study

Laromestrocel decreases soluble TIE2 in humans.
“increasing doses of laromestrocel are associated with decreases in soluble (degraded) tyrosine kinase with immunoglobulin and epidermal growth factor homology domains (TIE2)”
Human trial
Randomized phase 2b dose-escalation trial of stem cell therapy with laromestrocel for aging frailty
Cell stem cell25 Feb 2026

More on Laromestrocel

Latest

2 in 12 months

International Journal of Molecular Sciences15 Sep

Safety and Efficacy of Mesenchymal Stem Cell Therapy in Aging Frailty: A Systematic Review

Systematic review of randomised trialsMesenchymal stem cells

Cell Stem Cell27 Feb

Randomized phase 2b dose-escalation trial of stem cell therapy with laromestrocel for aging frailty

Randomised trial in 148 peopleInterventions